Reduction of norepinephrine versus vasopressin in the stabilization phase of septic shock: RENOVA clinical trial Cássio Mallmann; Thizá Maria Bianchi Galiotto; Michele Salibe de Oliveira; Rafael Barberena Moraes;

Fármacos vasoactivos en el tratamiento del shock séptico D. Andaluz-Ojeda; M.L. Cantón-Bulnes; C. Pey Richter; J. Garnacho-Montero;